WJB-001

N/A

Report date: 2025/05/27 14:25:54
NME

Base Information

Drug NameWJB-001
Drug Alias NameWJB001WJB-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase WEE1 inhibitors
TargetsSerine/threonine-protein kinase WEE1
Therapy Area/IndicationsSolid tumoursuterine serous carcinomaFallopian Tube Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesWigen Biomedicine technology (Shanghai) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesWigen Biomedicine technology (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursuterine serous carcinomaFallopian Tube Neoplasms +[5] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A